Fraction C significantly upregulated the expression of CD80 and MHC-II on D1 cells in a dose-dependent manner (Figure 3a) with no relevant cytotoxicity on the tumor cell lines (Figure 3b). The gene discussed is CD80; the disease is neoplasm.